DEL and Display Technologies Empower Discovery of Peptide Drugs
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
Continue ReadingKnowledge Library
D2B: Direct-to-Biology Platform
Looking for a solution to accelerate your drug discovery processes? WuXi AppTec’s integrated Direct-to-Biology (D2B) platform is a cost-effective and...
Continue Reading
Fully Automated HTS Platform for Screening Diverse Targets
High-throughput screening (HTS) remains a foundational technology in early drug discovery, responsible for identifying approximately one-third of today’s clinical candidates....
Continue Reading
Innovative Technologies in Early Drug Discovery
In this webinar, WuXi AppTec scientists discuss the latest innovative technologies and products in early-stage drug discovery. Viewers will gain...
Continue Reading
DELvision: A Protein-DEL Interaction Database
Currently, there is a lack of efficient experimental strategies to collect high-quality proteome-level data for protein-ligand interactions (PLIs). At DEL...
Continue Reading
Advanced On-bead DEL Technology for Enhanced Drug Discovery Screening
DNA-encoded library (DEL) technology has been recognized as a major screening method with unique advantages for offering vast chemical diversity...
Continue Reading
Discovery of a Novel Covalent Inhibitor Using DEL
With advancements in drug design, there is resurging interest in drugs that form covalent bonds with their targets. Covalent drugs...
Continue Reading
DEL Screening to Discover Small Molecule Ligands for RNA
RNA-targeted therapeutics are highly intriguing due to their unique physiological properties and novel modes of action in drug R&D. Developing...
Continue Reading
Discovery of a Selective BET Inhibitor for Treating Osteoarthritis
Bromodomain and extra-terminal domain (BET) family proteins are key regulators of gene transcription and have been implicated in a wide...
Continue Reading